Matching slides 303,780
Current window 104,911-104,940
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

104,911-104,940 of 303,780

filter-aware
63
The chart shows a clear upward trend in ANA prevalence over time, supporting the 'market growth' theme.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
64
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
65
The slide uses a side-by-side comparison framework to map market needs to specific R&D/innovation focus areas.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
66
The chart uses a stacked bar format to illustrate the shift from 5% U.S. revenue in 2017 to a 40% future goal.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
67
Uses a causal chain/additive logic to explain growth components.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
68
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
71
The slide uses a simple flow diagram to connect strategic initiatives to a financial outcome.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
72
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
73
The slide uses a choropleth map for the US and a list of country-specific metrics for international comparison.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
74
The chart shows the growth of conditions approved for newborn screening (NBS) from 54 in 2007 to 64 in 2024.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
75
The slide highlights two key innovation areas: Metachromatic Leukodystrophy (MLD) and Next Generation Sequencing (NGS) for newborn screening.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
79
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
80
The slide uses a stacked bar chart to show the shift in medical focus and a process-like diagram to list the pillars of the new era.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
81
The slide uses a path-based journey framework to illustrate the end-to-end process from drug discovery to patient monitoring.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
82
The diagram uses a hub-and-spoke style with a central 'Customer Needs' node connected to six peripheral nodes, which are also interconnected.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
83
The slide uses a visual flow to represent M&A activity culminating in the Revvity brand.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
84
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
85
The slide uses a value chain / process flow diagram to illustrate how the company's business units align with the drug and diagnostic development lifecycle.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
86
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
90
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
91
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
93
The slide uses a color-coded approach (purple for 2019, yellow for 2024E) to highlight performance improvement.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
94
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
95
The slide uses a three-column layout to group initiatives under functional areas.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
96
LSD = Low Single Digit, MSD = Mid Single Digit. The slide shows a shift in revenue and margin profiles due to organizational restructuring.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
97
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
98
LRP stands for Long-range plan. HSD = High Single Digit, LDD = Low Double Digit, LSD = Low Single Digit.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Waterfall Value1 hit
99
The slide uses a hub-and-spoke style diagram to connect the central metric to the three drivers.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Waterfall Value1 hit
100
The slide highlights the Revvity Operating Model and the expected growth rates for SG&A and R&D relative to revenue.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Waterfall Value1 hit
101
The slide uses a waterfall chart to bridge current performance to a future target.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Waterfall Value1 hit